These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32793355)

  • 1. Registration and local production of essential medicines in Uganda.
    Brhlikova P; Maigetter K; Murison J; Agaba AG; Tusiimire J; Pollock AM
    J Pharm Policy Pract; 2020; 13():31. PubMed ID: 32793355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda.
    Baldeh AO; Millard C; Pollock AM; Brhlikova P
    J Pharm Policy Pract; 2023 Jan; 16(1):18. PubMed ID: 36717871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis.
    Green A; Lyus R; Ocan M; Pollock AM; Brhlikova P
    J R Soc Med; 2023 Oct; 116(10):331-342. PubMed ID: 37343667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal.
    Brhlikova P; Harper I; Subedi M; Bhattarai S; Rawal N; Pollock AM
    Global Health; 2015 Jun; 11():25. PubMed ID: 26072308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
    Narsai K; Williams A; Mantel-Teeuwisse AK
    South Med Rev; 2012 Jul; 5(1):31-7. PubMed ID: 23093897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
    Chivukula MV; Tisocki K
    WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list.
    Naicker I; Suleman F; Perumal-Pillay VA
    J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer medicines in Pakistan: An analysis of essential medicines lists.
    Shukar S; Anjum R; Zhang J; Babar ZU; Mobeen I; Yang C
    J Oncol Pharm Pract; 2024 Jan; 30(1):46-54. PubMed ID: 37006130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of access to childhood cancer medicines: a comparative, mixed-methods analysis of four Caribbean countries.
    Boateng R; Petricca K; Tang B; Parikh S; SinQuee-Brown C; Alexis C; Browne-Farmer C; Reece-Mills M; Salmon SM; Bodkyn C; Gupta S; Maguire B; Denburg AE
    Lancet Glob Health; 2021 Sep; 9(9):e1314-e1324. PubMed ID: 34416215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus.
    Babatunde D; Pollock AM; Ocan M; Brhlikova P
    JRSM Open; 2024 Mar; 15(3):20542704241232814. PubMed ID: 38560365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of government agencies and other actors in influencing access to medicines in three East African countries.
    Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
    Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Civil Society Organizations and medicines policy change: a case study of registration, procurement, distribution and use of misoprostol in Uganda.
    Atukunda EC; Brhlikova P; Agaba AG; Pollock AM
    Soc Sci Med; 2015 Apr; 130():242-9. PubMed ID: 25728484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.
    Tauqeer F; Myhr K; Gopinathan U
    Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting an appropriate strategy to make quality 7.1 % chlorhexidine digluconate accessible for umbilical cord care.
    Metzler M; Coffey PS
    J Pharm Policy Pract; 2016; 9():14. PubMed ID: 27066258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaps and opportunities in sustainable medicines use in resource limited settings: A situational analysis of Uganda.
    Kamba PF; Nambatya W; Aguma HB; Charani E; Rajab K
    Br J Clin Pharmacol; 2022 Sep; 88(9):3936-3942. PubMed ID: 35342977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential Medicines in a High Income Country: Essential to Whom?
    Duong M; Moles RJ; Chaar B; Chen TF;
    PLoS One; 2015; 10(12):e0143654. PubMed ID: 26650544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access and use of WHO essential medicines in Italy.
    Petrella A; Fortinguerra F; Cangini A; Pierantozzi A; Trotta F
    Front Public Health; 2023; 11():1211208. PubMed ID: 37881343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
    Babar ZU; Lessing C; Mace C; Bissell K
    Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
    Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
    BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018.
    Lyus R; Pollock A; Ocan M; Brhlikova P
    Bull World Health Organ; 2020 Aug; 98(8):530-538. PubMed ID: 32773898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.